HomeInvestors HealthAscendis Pharma GAAP EPS of -€1.91, revenue of €36M; revises FY24 revenue...

Ascendis Pharma GAAP EPS of -€1.91, revenue of €36M; revises FY24 revenue outlook

525-5250815_gold-ball-free-png-gold-ball-png-clipart

September 4, 2024

Ascendis Pharma GAAP EPS of -€1.91, revenue of €36M; revises FY24 revenue outlook

Source link

Previous article

Forget the Average Retirement Savings for Americans. Here’s a Better Way to Set Yourself Up for a Comfortable Retirement.

Next article

BRF Is Already Priced For Peak Margins, With Poultry Cycles Peaking

Investors Health Image

latest articles

explore more

LEAVE A REPLY Cancel reply

Please enter your comment!

Please enter your name here

You have entered an incorrect email address!

Please enter your email address here